Medical device firm Respiratory Motion has received the CE Mark for ExSpiron respiratory minute ventilation monitor.


The device allows clinicians to track and trend respiratory depression faster.

The company first introduced the device to the European medical community during presentations by key opinion leaders at the Deutscher Anesthesia Congress, the annual meeting of the Society of German Anesthesiologists held last month.

Findings from five studies using the ExSpiron patient monitor showed enthusiasm in implementing minute ventilation monitoring for greater titration of opioids in PACUs and in general wards.

The trials also demonstrated to immediately see and respond to respiratory depression in patients administered anesthetics during procedural sedation cases.

Respiratory Motion CEO Jenny Freeman said: "Clinicians around the world rely on Minute Ventilation (MV) to make decisions on the respiratory status of patients on mechanical ventilators.

"ExSpiron is the only medical device able to provide this measurement in a patient monitor, offering immediate insight into a patients’ respiratory status than what is available in the market today."

ExSpiron measures respiratory volume and rate for non-intubated patients. The system includes real-time waveforms, trends and numeric displays.

It also includes touch screen graphical user interface for clear display, a disposable Patient PadSet technology, and self-contained 2+ hour battery.

ExSpiron features IV pole mount, USB connectivity, EHR integration options, nurse call interface, Philips VueLink/IntelliBridge.

Image: ExSpiron Minute Ventilation Monitor. Photo: courtesy of PR Newswire.